Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 053005/0933 | |
| Pages: | 2 |
| | Recorded: | 06/22/2020 | | |
| Attorney Dkt #: | UCLA.258USWO |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/15/2022
|
Application #:
|
16753962
|
Filing Dt:
|
04/06/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/10/2020
| | | | |
|
Title:
|
OLMALINC AS A DIAGNOSTIC AND THERAPEUTIC TARGET FOR NAFLD, NASH, METABOLIC SYNDROME, AND HEPATIC FIBROSIS
|
|
|
Assignee
|
|
|
|
|
| 1111 FRANKLIN STREET |
| TWELFTH FLOOR |
| OAKLAND, CALIFORNIA 94607-5200 |
|
|
Correspondence name and address
|
| |
CANADY + LORTZ LLP
|
| |
3701 WILSHIRE BLVD
|
| |
SUITE 508
|
| |
LOS ANGELES, CA 90010
|
Search Results as of:
05/08/2024 03:25 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
